Bioprotocol ( BIO ) is advancing its cross chain DeFi suite, boosting adoption across its growing ecosystem. Meanwhile, Tezos ( XTZ ) continues to attract institutional interest with formal verification technology, driving sustained trading activity. Beam ( BEAM ) sees renewed liquidity as privacy focused users explore its scalable sidechain solutions, reflecting positive investor sentiment.